BioMarin Pharma (BMRN) Tops Q3 EPS by 5c
Tweet
Share
E-mail
Get Alerts BMRN Hot Sheet
Price: $67.36 -1.71%
Financial Fact:
NET INCOME (LOSS): -42.8M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
NET INCOME (LOSS): -42.8M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
BioMarin Pharma (NASDAQ: BMRN) reported Q3 GAAP EPS of ($0.07), $0.05 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $334.1 million versus the consensus estimate of $349.59 million.
GUIDANCE:
BioMarin Pharma sees FY2017 revenue of $1.29-1.32 billion, versus the consensus of $1.31 billion.
For earnings history and earnings-related data on BioMarin Pharma (BMRN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
